Report Detail
Global Personalized Medicine Market Size, Status and Forecast 2019-2025
- RnM3040729 |
- 28 February, 2019 |
- Global |
- 105 Pages |
- QYResearch |
- Other
Individualized medication, medication "vary from person to person" , give full consideration to each patient's genetic factors, gender, age, body weight, physiological and pathological characteristics, and are taking other drugs on the basis of the comprehensive situation of safe, reasonable, effective and economic drug treatment.
In 2018, the global Personalized Medicine market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Personalized Medicine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Personalized Medicine development in United States, Europe and China.
The key players covered in this study
Abbott Laboratories
Agilent Technologies
Amgen
Astellas Pharma
Astrazeneca
Bayer AG
Celgene Corporation
Glaxosmithkline Plc
Illumina
Johnson & Johnson
Laboratory Corporation
Merck
Novartis AG
Roche Holding AG
Siemens AG
Takeda Pharmaceutical Company Limited
Market segment by Type, the product can be split into
Personalized Medicine Diagnostics
Personalized Medical Care
Personalized Medicine Therapeutics
Personalized Nutrition and Wellness
Market segment by Application, split into
Oncology
Central Nervous System (CNS)
Immunology
Respiratory
Other Applications
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Personalized Medicine status, future forecast, growth opportunity, key market and key players.
To present the Personalized Medicine development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Personalized Medicine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Personalized Medicine Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Personalized Medicine Diagnostics
- 1.4.3 Personalized Medical Care
- 1.4.4 Personalized Medicine Therapeutics
- 1.4.5 Personalized Nutrition and Wellness
- 1.5 Market by Application
- 1.5.1 Global Personalized Medicine Market Share by Application (2014-2025)
- 1.5.2 Oncology
- 1.5.3 Central Nervous System (CNS)
- 1.5.4 Immunology
- 1.5.5 Respiratory
- 1.5.6 Other Applications
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Personalized Medicine Market Size
- 2.2 Personalized Medicine Growth Trends by Regions
- 2.2.1 Personalized Medicine Market Size by Regions (2014-2025)
- 2.2.2 Personalized Medicine Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
3 Market Share by Key Players
- 3.1 Personalized Medicine Market Size by Manufacturers
- 3.1.1 Global Personalized Medicine Revenue by Manufacturers (2014-2019)
- 3.1.2 Global Personalized Medicine Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global Personalized Medicine Market Concentration Ratio (CR5 and HHI)
- 3.2 Personalized Medicine Key Players Head office and Area Served
- 3.3 Key Players Personalized Medicine Product/Solution/Service
- 3.4 Date of Enter into Personalized Medicine Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Personalized Medicine Market Size by Type (2014-2019)
- 4.2 Global Personalized Medicine Market Size by Application (2014-2019)
5 United States
- 5.1 United States Personalized Medicine Market Size (2014-2019)
- 5.2 Personalized Medicine Key Players in United States
- 5.3 United States Personalized Medicine Market Size by Type
- 5.4 United States Personalized Medicine Market Size by Application
6 Europe
- 6.1 Europe Personalized Medicine Market Size (2014-2019)
- 6.2 Personalized Medicine Key Players in Europe
- 6.3 Europe Personalized Medicine Market Size by Type
- 6.4 Europe Personalized Medicine Market Size by Application
7 China
- 7.1 China Personalized Medicine Market Size (2014-2019)
- 7.2 Personalized Medicine Key Players in China
- 7.3 China Personalized Medicine Market Size by Type
- 7.4 China Personalized Medicine Market Size by Application
8 Japan
- 8.1 Japan Personalized Medicine Market Size (2014-2019)
- 8.2 Personalized Medicine Key Players in Japan
- 8.3 Japan Personalized Medicine Market Size by Type
- 8.4 Japan Personalized Medicine Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Personalized Medicine Market Size (2014-2019)
- 9.2 Personalized Medicine Key Players in Southeast Asia
- 9.3 Southeast Asia Personalized Medicine Market Size by Type
- 9.4 Southeast Asia Personalized Medicine Market Size by Application
10 India
- 10.1 India Personalized Medicine Market Size (2014-2019)
- 10.2 Personalized Medicine Key Players in India
- 10.3 India Personalized Medicine Market Size by Type
- 10.4 India Personalized Medicine Market Size by Application
11 Central & South America
- 11.1 Central & South America Personalized Medicine Market Size (2014-2019)
- 11.2 Personalized Medicine Key Players in Central & South America
- 11.3 Central & South America Personalized Medicine Market Size by Type
- 11.4 Central & South America Personalized Medicine Market Size by Application
12 International Players Profiles
- 12.1 Abbott Laboratories
- 12.1.1 Abbott Laboratories Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Personalized Medicine Introduction
- 12.1.4 Abbott Laboratories Revenue in Personalized Medicine Business (2014-2019)
- 12.1.5 Abbott Laboratories Recent Development
- 12.2 Agilent Technologies
- 12.2.1 Agilent Technologies Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Personalized Medicine Introduction
- 12.2.4 Agilent Technologies Revenue in Personalized Medicine Business (2014-2019)
- 12.2.5 Agilent Technologies Recent Development
- 12.3 Amgen
- 12.3.1 Amgen Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Personalized Medicine Introduction
- 12.3.4 Amgen Revenue in Personalized Medicine Business (2014-2019)
- 12.3.5 Amgen Recent Development
- 12.4 Astellas Pharma
- 12.4.1 Astellas Pharma Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Personalized Medicine Introduction
- 12.4.4 Astellas Pharma Revenue in Personalized Medicine Business (2014-2019)
- 12.4.5 Astellas Pharma Recent Development
- 12.5 Astrazeneca
- 12.5.1 Astrazeneca Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Personalized Medicine Introduction
- 12.5.4 Astrazeneca Revenue in Personalized Medicine Business (2014-2019)
- 12.5.5 Astrazeneca Recent Development
- 12.6 Bayer AG
- 12.6.1 Bayer AG Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Personalized Medicine Introduction
- 12.6.4 Bayer AG Revenue in Personalized Medicine Business (2014-2019)
- 12.6.5 Bayer AG Recent Development
- 12.7 Celgene Corporation
- 12.7.1 Celgene Corporation Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Personalized Medicine Introduction
- 12.7.4 Celgene Corporation Revenue in Personalized Medicine Business (2014-2019)
- 12.7.5 Celgene Corporation Recent Development
- 12.8 Glaxosmithkline Plc
- 12.8.1 Glaxosmithkline Plc Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Personalized Medicine Introduction
- 12.8.4 Glaxosmithkline Plc Revenue in Personalized Medicine Business (2014-2019)
- 12.8.5 Glaxosmithkline Plc Recent Development
- 12.9 Illumina
- 12.9.1 Illumina Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Personalized Medicine Introduction
- 12.9.4 Illumina Revenue in Personalized Medicine Business (2014-2019)
- 12.9.5 Illumina Recent Development
- 12.10 Johnson & Johnson
- 12.10.1 Johnson & Johnson Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Personalized Medicine Introduction
- 12.10.4 Johnson & Johnson Revenue in Personalized Medicine Business (2014-2019)
- 12.10.5 Johnson & Johnson Recent Development
- 12.11 Laboratory Corporation
- 12.12 Merck
- 12.13 Novartis AG
- 12.14 Roche Holding AG
- 12.15 Siemens AG
- 12.16 Takeda Pharmaceutical Company Limited
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Personalized Medicine . Industry analysis & Market Report on Personalized Medicine is a syndicated market report, published as Global Personalized Medicine Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Personalized Medicine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
